These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22214845)

  • 1. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.
    Jing L; Haas J; Chong TM; Bruckner JJ; Dann GC; Dong L; Marshak JO; McClurkan CL; Yamamoto TN; Bailer SM; Laing KJ; Wald A; Verjans GM; Koelle DM
    J Clin Invest; 2012 Feb; 122(2):654-73. PubMed ID: 22214845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
    van Velzen M; Jing L; Osterhaus AD; Sette A; Koelle DM; Verjans GM
    PLoS Pathog; 2013 Aug; 9(8):e1003547. PubMed ID: 23966859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncognate Signals Drive Enhanced Effector CD8
    Gmyrek GB; Predki P; Gershburg E; Carr DJJ
    J Virol; 2022 Mar; 96(6):e0172421. PubMed ID: 35045268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.
    Jing L; Schiffer JT; Chong TM; Bruckner JJ; Davies DH; Felgner PL; Haas J; Wald A; Verjans GM; Koelle DM
    J Virol; 2013 Mar; 87(5):2617-27. PubMed ID: 23255792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Priming of Herpes Simplex Virus-Specific CD8
    Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
    Mikloska Z; Cunningham AL
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
    Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8
    Vahed H; Agrawal A; Srivastava R; Prakash S; Coulon PA; Roy S; BenMohamed L
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
    Dropulic LK; Oestreich MC; Pietz HL; Laing KJ; Hunsberger S; Lumbard K; Garabedian D; Turk SP; Chen A; Hornung RL; Seshadri C; Smith MT; Hosken NA; Phogat S; Chang LJ; Koelle DM; Wang K; Cohen JI
    J Infect Dis; 2019 Aug; 220(6):990-1000. PubMed ID: 31058977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
    Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL
    J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes.
    Sheridan BS; Cherpes TL; Urban J; Kalinski P; Hendricks RL
    J Virol; 2009 Mar; 83(5):2237-45. PubMed ID: 19073721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.
    Rajasagi NK; Kassim SH; Kollias CM; Zhao X; Chervenak R; Jennings SR
    J Virol; 2009 May; 83(10):5256-68. PubMed ID: 19279095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2.
    Posavad CM; Magaret AS; Zhao L; Mueller DE; Wald A; Corey L
    Vaccine; 2011 Sep; 29(40):7058-66. PubMed ID: 21801778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.